BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34142888)

  • 1. DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy.
    Ferguson BS; Wennersten SA; Demos-Davies KM; Rubino M; Robinson EL; Cavasin MA; Stratton MS; Kidger AM; Hu T; Keyse SM; McKnight RA; Lane RH; Nozik ES; Weiser-Evans MCM; McKinsey TA
    Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H382-H389. PubMed ID: 34142888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension.
    Dai J; Zhou Q; Tang H; Chen T; Li J; Raychaudhuri P; Yuan JX; Zhou G
    Cell Signal; 2018 Nov; 51():119-129. PubMed ID: 30092353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
    Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension.
    Guo M; Zhang M; Cao X; Fang X; Li K; Qin L; He Y; Zhao J; Xu Y; Liu X; Li X
    Respir Res; 2022 Jan; 23(1):6. PubMed ID: 35016680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.
    Sun M; Ramchandran R; Chen J; Yang Q; Raj JU
    Am J Respir Cell Mol Biol; 2016 Dec; 55(6):779-791. PubMed ID: 27438786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
    Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
    Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.
    Paffett ML; Lucas SN; Campen MJ
    Vascul Pharmacol; 2012; 56(1-2):64-73. PubMed ID: 22146233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
    Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W
    Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
    Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary artery smooth muscle cell endothelin-1 expression modulates the pulmonary vascular response to chronic hypoxia.
    Kim FY; Barnes EA; Ying L; Chen C; Lee L; Alvira CM; Cornfield DN
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L368-77. PubMed ID: 25399435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
    Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
    Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-type natriuretic peptide inhibits angiotensin II-induced proliferation and migration of pulmonary arterial smooth muscle cells.
    Hsu JH; Liou SF; Yang SN; Wu BN; Dai ZK; Chen IJ; Yeh JL; Wu JR
    Pediatr Pulmonol; 2014 Aug; 49(8):734-44. PubMed ID: 24167111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension.
    Iglarz M; Landskroner K; Bauer Y; Vercauteren M; Rey M; Renault B; Studer R; Vezzali E; Freti D; Hadana H; Schläpfer M; Cattaneo C; Bortolamiol C; Weber E; Whitby BR; Delahaye S; Wanner D; Steiner P; Nayler O; Hess P; Clozel M
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):457-67. PubMed ID: 26230396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females.
    Dempsie Y; Nilsen M; White K; Mair KM; Loughlin L; Ambartsumian N; Rabinovitch M; Maclean MR
    Respir Res; 2011 Dec; 12(1):159. PubMed ID: 22185646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction.
    Peng LY; Yu M; Yang MX; Liu P; Zhou H; Huang W; Kong H; Xie WP
    Am J Hypertens; 2020 Aug; 33(8):775-783. PubMed ID: 32301965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paeonol regulates hypoxia-induced proliferation of pulmonary artery smooth muscle cells via EKR 1/2 signalling.
    Zhang L; Ma C; Gu R; Zhang M; Wang X; Yang L; Liu Y; Zhou Y; He S; Zhu D
    Eur J Pharmacol; 2018 Sep; 834():257-265. PubMed ID: 30053410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.